Skip to main content
Clinical Trials/CTRI/2020/01/023012
CTRI/2020/01/023012Not yet recruitingPhase 2

Effect of a Unani formulation on menstrual cyclicity in women with Polycystic Ovarian Syndrome - A single arm open labelled observational study

ational Institute of Unani Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient in age group of 20-38 years.
  • Patient meeting Rotterdam criteria20 (2 out of 3 criteria)
  • Oligovulation or anovulation(Oligo oramenorrhoea) and
  • Clinical evidence of Hyperandrogenism (acne, hirsutism) or
  • Ultrasound finding of polycystic ovaries

Exclusion Criteria

  • Patients with
  • Thyroid dysfunction, hyperprolactinemia,Systemic illnesses, malignancy, morbid obesity, H/o using hormonal pills & insulin sensitizers within 3 months of study enrollment,Pregnancy and lactation.

Investigators

Sponsor
ational Institute of Unani Medicine

Similar Trials